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Mitral Valve Prolapse
A Deeper Look*
Robert A. Levine, MD, FACC, Ronen Durst, MD
Boston, MassachusettsTwo myths have been prevalent regarding heart
valve disease: that the valves are simply mechanical
flaps, and that the importance to the patient of
regurgitation in particular relates almost entirely to
ventricular function only. The paper in this issue of
JACC: Cardiovascular Imaging by Han et al. (1)
provides a more comprehensive picture that coun-
terbalances these concepts.
See page 294
The investigators set out to characterize mitral
valve prolapse (MVP) by cardiovascular magnetic
resonance (CMR) imaging, and found it could
match the diagnostic sensitivity and specificity of
transthoracic echocardiography. The 3-dimensional
(3D) CMR image can be sectioned in a parallel
series of long-axis views to analyze segmental anat-
omy and provide a “road map” for repair (2). There
are several messages from this study pertinent to
cardiovascular imaging: 1) Understanding the basic
principles of image acquisition affects interpretation
of results—CMR provides a blunted measure of
leaflet thickness and, to a lesser extent, leaflet
length, likely caused by a partial volume effect from
surrounding blood pool. 2) Three-dimensional ac-
quisitions achieve their maximum value by provid-
ing not only 3D images but also spatially registered
2D views to explore segmental anatomy, as dis-
played admirably by O’Gara et al. (3) for 3D
transesophageal echocardiography in the March
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acquisition has therefore contributed in many ways
to our understanding of mitral valve disease, includ-
ing improved diagnostic specificity, inspiration for
annuloplasty ring design, and analysis of valve me-
chanics based on showing the 3D saddle shape of the
valve (4–10). A caveat is that the most useful segmen-
tal anatomy may be best derived from nonparallel
views transecting the mitral coaptation line to intersect
opposing central, medial, and lateral segments of
both leaflets derived from a 3D scout view (3,11).
The greatest novelty comes from the deeper and
more profound look that CMR provides into the
biology of the valve and its linked myocardium,
made possible in part by a technological advance,
the improved spatial resolution provided by 3D
acquisition of images with delayed gadolinium (Gd)
enhancement. Such enhancement occurs when the
kinetics of Gd excretion is different in 2 adjacent
compartments, so that over time, one compartment
enhances more than the other. This has been a
powerful tool for delineating infarcted and scarred
myocardium, which excrete Gd slower than viable
tissue (12–15). Han et al. (1) report frequently
delayed Gd enhancement in both the mitral leaflets
themselves and the papillary muscle (PM) tips in
patients with MVP and not in control subjects.
This complementary and unique tissue character-
ization requires further exploration, but indicates
biological differences in both the valve tissue and
the myocardium directly linked to it.
Delayed Gd enhancement reinforces understand-
ing of the myxomatous valve as one in which the
processes of altered cell and extracellular matrix
biology, normally quiescent in adult life, are reacti-
vated (16,17). Noninvasive imaging may therefore
be of value in confirming such intrinsic changes,
with potential for strengthening phenotypic char-
acterization in genetic studies of familial MVP
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30518 –21) and monitoring response to therapies tar-
eting hyperactive growth factor stimulation
22,23). The altered PM tip appearance in patients
ith MVP may provide insight into the intriguing
uestion of ventricular arrhythmias in MVP and the
ccurrence of sudden death with elongated leaflets
lone, even in the absence of important mitral
egurgitation or heart failure (24 –27). The pathol-
gy literature also includes evidence for localized
entricular changes in patients with MVP (28 –30).
e can speculate that the PM is altered by repet-
tive traction exerted by the prolapsing leaflets (Fig.
) (31), which has been shown experimentally to
ower the threshold for lethal arrhythmias (32).
itral valve disease is therefore not a bystander but
 primary actor in the entire clinical picture. We
ave recently recognized that mitral regurgitation
lays an independent role in altering the biology of
he remodeling ventricle after myocardial infarction
33,34), and strongly determines prognosis in the
on-ischemic setting as well (35,36). This CMR
tudy suggests a direct impact of the prolapsing
alve on a ventricular structure. The PM damage may
n turn exacerbate prolapse in a vicious cycle, poten-
ially explaining the frequently observed but as yet
nexplained mid to late systolic onset of leaflet dis-
lacement, characteristic of the yield stress phenome-
on in mechanical engineering in response to a critical
hreshold overcoming a counteracting force (Ajit P.
oganathan, PhD, personal communication, 1996).
In summary, the study by Han et al. (1) rein-
orces a new way of thinking of standardizingfilippo AJ, et al. Three-dimensional Suppl:I458–62.ges in registered 2D views. It provides a deeper
nd more profound look into valve biology and the
mpact of valvular heart disease on the myocardium
o which it is inseparably linked, with the potential
o monitor, understand, and ultimately treat under-
ying pathophysiological mechanisms.
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